Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Kauffman Michael Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Disposed/sold 37,000 options to buy @ $9.39, valued at $347.4k
Granted 37,000 options to buy @ $0
Disposed/sold 18,500 options to buy @ $11.49, valued at $212.6k
Granted 18,500 options to buy @ $0
Disposed/sold 26,400 options to buy @ $5.195, valued at $137.1k
Granted 26,400 options to buy @ $0
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/02/2023 4 Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Granted 5,900 shares @ $0
Granted 26,400 options to buy @ $5.195, valued at $137.1k
05/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
06/24/2022 4 Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $1.11, valued at $69.4k
06/17/2022 4 Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 26,000 options to buy @ $4.8, valued at $124.8k
06/03/2022 4 Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Granted 18,500 options to buy @ $11.49, valued at $212.6k
03/02/2022 4 Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 21,000 shares @ $0
Sold 6,226 shares @ $10.2375, valued at $63.7k
Sold 6,226 shares @ $10.2375, valued at $63.7k
Granted 27,000 options to buy @ $10.33, valued at $278.9k
02/22/2022 4 Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 9,079 shares @ $12.1234, valued at $110.1k
Sold 9,088 shares @ $12.1234, valued at $110.2k
02/09/2022 4 Kauffman Michael (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 6,764 shares @ $9.862, valued at $66.7k
Sold 6,707 shares @ $9.862, valued at $66.1k
01/05/2022 4 Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Sold 5,000 shares @ $16.45, valued at $82.3k
Exercised 5,000 options to buy @ $5.91, valued at $29.6k
11/18/2021 4 Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns: Granted 37,000 options to buy @ $9.39, valued at $347.4k
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 25,000 options to buy @ $4.16, valued at $104k
03/23/2021 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 4,000 shares @ $12.3882, valued at $49.6k
03/01/2021 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 57,200 shares @ $0
Granted 57,200 shares @ $0
Granted 153,500 options to buy @ $14.56, valued at $2.2M
Granted 153,500 options to buy @ $14.56, valued at $2.2M
02/22/2021 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 9,495 shares @ $14.8312, valued at $140.8k
Sold 9,495 shares @ $14.8312, valued at $140.8k
02/17/2021 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 6,601 shares @ $15.519, valued at $102.4k
Sold 6,642 shares @ $15.519, valued at $103.1k
Exercised 21,800 restricted stock units @ $0
Exercised 21,800 restricted stock units @ $0
02/09/2021 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Exercised 14,300 restricted stock units @ $0
Exercised 14,300 restricted stock units @ $0
10/14/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,500 shares @ $14.891, valued at $111.7k
Exercised 1,424 options to buy @ $0.033, valued at $47
Exercised 6,076 options to buy @ $0.033, valued at $200.5
08/18/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 1,477 shares @ $15, valued at $22.2k
Exercised 1,477 options to buy @ $0.033, valued at $48.7
07/17/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,500 shares @ $19.4297, valued at $145.7k
Exercised 7,500 options to buy @ $0.033, valued at $247.5
07/13/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,200 shares @ $18.976, valued at $136.6k
Sold 300 shares @ $19.7067, valued at $5.9k
Sold 7,500 shares @ $19.5316, valued at $146.5k
Exercised 7,500 options to buy @ $4.752, valued at $35.6k
Exercised 7,500 options to buy @ $4.752, valued at $35.6k
06/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,500 shares @ $20, valued at $150k
Exercised 7,500 options to buy @ $0.033, valued at $247.5
06/18/2020 4 Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 25,000 options to buy @ $1.77, valued at $44.3k
06/17/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,143 shares @ $16.3791, valued at $117k
Sold 357 shares @ $16.2, valued at $5.8k
Exercised 7,143 options to buy @ $0.033, valued at $235.7
Exercised 357 options to buy @ $0.033, valued at $11.8
06/11/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,500 shares @ $18.1259, valued at $135.9k
Sold 7,500 shares @ $18.4994, valued at $138.7k
Exercised 7,500 options to buy @ $4.752, valued at $35.6k
Exercised 7,500 options to buy @ $4.752, valued at $35.6k
05/19/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 7,500 shares @ $18.6454, valued at $139.8k
Sold 7,500 shares @ $20, valued at $150k
Exercised 7,500 options to buy @ $0.033, valued at $247.5
Exercised 7,500 options to buy @ $0.033, valued at $247.5
05/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/10/2020 4 Kauffman Michael (CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Sold 10,000 shares @ $20.6404, valued at $206.4k
Sold 10,000 shares @ $18.6115, valued at $186.1k
Exercised 10,000 options to buy @ $4.752, valued at $47.5k
Exercised 10,000 options to buy @ $4.752, valued at $47.5k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy